THE HEPATIC INTERLEUKIN-6 RECEPTOR - DOWN-REGULATION OF THE INTERLEUKIN-6 BINDING SUBUNIT (GP80) BY ITS LIGAND

被引:122
|
作者
ZOHLNHOFER, D [1 ]
GRAEVE, L [1 ]
ROSEJOHN, S [1 ]
SCHOOLTINK, H [1 ]
DITTRICH, E [1 ]
HEINRICH, PC [1 ]
机构
[1] RHEIN WESTFAL TH AACHEN,INST BIOCHEM,PAUWELSSTR 30,W-5100 AACHEN,GERMANY
关键词
HEPATIC IL6-RECEPTOR; INTERLEUKIN-6; INTERNALIZATION; DOWN-REGULATION; SIGNAL TRANSDUCTION;
D O I
10.1016/0014-5793(92)81004-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-6 (IL6) exerts its action via a cell surface receptor composed of an 80 kDa IL6-binding protein (gp80) and a 130 kDa polypeptide involved in signal transduction (gp130). We studied the role of gp80 in binding, internalization and down-regulation of the hepatic IL6-receptor (IL6R) by its ligand in human hepatoma cells (HepG2). Comparison of transfected HepG2 cells overexpressing gp80 with parental cells indicate that gp80 is responsible for low affinity binding (K(d) = 500 pM) of IL6. Furthermore, gp80 is rate-limiting in internalization and degradation of IL6. Internalization resulted in a rapid down-regulation (t1/2 almost-equal-to 15-30 min) of IL6-binding sites at the cell surface. More than 80% of the internalized [I-125]rhIL6 was degraded. The reappearance of IL6-binding sites at the cell surface required >8 h and was sensitive to cycloheximide, suggesting that gp80 is not recycled after internalization. The down-regulation of the hepatic IL6R by its ligand might play an important role as a protection against overstimulation.
引用
收藏
页码:219 / 222
页数:4
相关论文
共 50 条
  • [31] Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 Receptor
    Adam, Nina
    Rabe, Bjoern
    Suthaus, Jan
    Groetzinger, Joachim
    Rose-John, Stefan
    Scheller, Juergen
    JOURNAL OF VIROLOGY, 2009, 83 (10) : 5117 - 5126
  • [32] A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130
    Graeve, L
    Korolenko, TA
    Hemmann, U
    Weiergraber, O
    Dittrich, E
    Heinrich, PC
    FEBS LETTERS, 1996, 399 (1-2) : 131 - 134
  • [33] Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer
    Wouters, M. C. A.
    Dijkgraaf, E. M.
    Kuijjer, M. L.
    Jordanova, E. S.
    Hollema, H.
    Welters, M. J. P.
    van der Hoeven, J. J. M.
    Daemen, T.
    Kroep, J. R.
    Nijman, H. W.
    van der Burg, S. H.
    ONCOIMMUNOLOGY, 2014, 3 (12): : 1 - 13
  • [34] Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts
    Vermes, C
    Jacobs, JJ
    Zhang, J
    Firneisz, G
    Roebuck, KA
    Glant, TT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) : 16879 - 16887
  • [35] Fusion protein of interleukin-6 and interleukin-6 receptor without a polypeptide linker
    Yasukawa, K
    Tsuchiya, S
    Ekida, T
    Iida, H
    Ide, T
    Miki, D
    Yagame, H
    Murayama, K
    Ishiguroi, T
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2003, 96 (01) : 38 - 46
  • [36] Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients
    Tomasz Dziedzic
    Elzbieta A. Gryz
    Wojciech Turaj
    Agnieszka Slowik
    Andrzej Szczudlik
    Journal of Molecular Neuroscience, 2004, 24 : 293 - 298
  • [37] Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients
    Dziedzic, T
    Gryz, EA
    Turaj, W
    Slowik, A
    Szczudlik, A
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 24 (02) : 293 - 298
  • [38] INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN LARGE-VESSEL VASCULITIDES
    Pulsatelli, L.
    Dolzani, P.
    Assirelli, E.
    Meliconi, R.
    Pipitone, N.
    Muratore, F.
    Pazzola, G.
    Boiardi, L.
    Salvarani, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 302 - 303
  • [39] Interleukin-6 soluble interleukin-6 receptor complex inhibits myocardial apoptosis
    Matsushita, K
    Iwanaga, S
    Oda, T
    Kimura, K
    Shimada, M
    Ogawa, S
    CIRCULATION, 1998, 98 (17) : 260 - 261
  • [40] Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
    Kampan, Nirmala Chandralega
    Xiang, Sue D.
    McNally, Orla M.
    Stephens, Andrew N.
    Quinn, Michael A.
    Plebanski, Magdalena
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (36) : 4785 - 4806